Ichiro Takada Selected Research

Ichiro Takada Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 08/2004
4	Williams Syndrome (Williams-Beuren Syndrome) 02/2014 - 06/2009
3	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 03/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2015
3	Metabolic Diseases (Metabolic Disease) 01/2020 - 02/2015
3	Inflammation (Inflammations) 01/2017 - 06/2012
3	Obesity 04/2005 - 02/2004
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2015
2	Stroke (Strokes) 06/2012 - 08/2009
1	Neuroblastoma 02/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Hypertriglyceridemia 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Carcinogenesis 01/2017
1	Colitis 01/2017
1	Vitamin D Deficiency 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Cardiovascular Infections 01/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 02/2016
1	Weight Gain 02/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Infections 01/2015
1	Fibrosis (Cirrhosis) 01/2015
1	Hypercalcemia (Milk Alkali Syndrome) 01/2015
1	Osteoporosis 04/2013
1	Infarction (Infarctions) 06/2012
1	Hepatitis 12/2009
1	Wounds and Injuries (Trauma) 12/2009
1	Bone Resorption 09/2009
1	Brain Injuries (Brain Injury) 08/2009
1	Brain Infarction 08/2009
1	Brain Ischemia (Cerebral Ischemia) 08/2009
1	Primary Ovarian Insufficiency 01/2006
1	Atherosclerosis 04/2005
1	Chronic Disease (Chronic Diseases) 02/2005
1	Breast Neoplasms (Breast Cancer) 12/2003
1	Necrosis 03/2003

Drug/Important Bio-Agent (IBA)

8	LigandsIBA 01/2020 - 03/2003
5	Transcription Factors (Transcription Factor)IBA 02/2014 - 03/2003
5	CytokinesIBA 06/2012 - 03/2003
4	Estrogens (Estrogen)FDA Link 04/2013 - 12/2003
3	PPAR gammaIBA 02/2005 - 03/2003
2	DNA HelicasesIBA 03/2023 - 01/2023
2	Carrier Proteins (Binding Protein)IBA 03/2023 - 01/2023
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2023 - 02/2022
2	ThiazolidinedionesIBA 01/2020 - 02/2015
2	MineralsIBA 01/2017 - 01/2015
2	Vitamin D FDA LinkGeneric 01/2017 - 01/2015
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2017 - 01/2015
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2005 - 02/2004
1	ChromatinIBA 03/2023
1	EnzymesIBA 03/2023
1	Sucrose (Saccharose)IBA 03/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 02/2022
1	Fibric Acids (Fibrates)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	BI D1870IBA 02/2016
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 02/2016
1	Estradiol Congeners (Synthetic Estrogens)IBA 04/2013
1	AntibodiesIBA 06/2012
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	PeroxiredoxinsIBA 06/2012
1	Alanine (L-Alanine)FDA Link 03/2011
1	Threonine (L-Threonine)FDA Link 03/2011
1	AndrogensIBA 03/2011
1	Androgen Antagonists (Antiandrogens)IBA 03/2011
1	Recombinant ProteinsIBA 12/2009
1	Adenosine Triphosphate (ATP)IBA 11/2009
1	Nucleosomes (Nucleosome)IBA 11/2009
1	Interleukin-23 (Interleukin 23)IBA 08/2009
1	Interleukin-17 (Interleukin 17)IBA 08/2009
1	Androgen Receptors (Androgen Receptor)IBA 01/2006
1	PPAR alphaIBA 04/2005
1	Mediator Complex Subunit 1IBA 08/2004
1	Selective Estrogen Receptor Modulators (SERM)IBA 12/2003
1	Tamoxifen FDA LinkGeneric 12/2003
1	Raloxifene Hydrochloride (Evista)FDA Link 12/2003
1	Interleukin-1 (Interleukin 1)IBA 03/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2003

Therapy/Procedure

2	Castration 03/2023 - 01/2023
1	Radiotherapy 03/2023
1	Therapeutics 03/2023
1	Molecular Targeted Therapy 01/2023